Ruth Lupu, PhD

Professor, Rochester, MN, Laboratory Medicine and Pathology

EmailLupu.Ruth@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Ruth Lupu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

7 Finished

Cyr61-induced breast cancer: Clinical relevance and therapeutic development
Lupu, R.
National Institutes of Health
8/18/06 → 7/31/12
Project: Research project
Fatty Acid Synthase /Molecular Target /Breast Cancer The
Lupu, R.
National Institutes of Health
9/16/05 → 6/30/16
Project: Research project
CENTER FOR CAM RESEARCH IN AGING
Lupu, R., Murphy, P. A., Kushi, L., Troxel, A., Bilezikian, J., Kronenberg, F. & Murphy, P. A.
National Institutes of Health
9/30/99 → 7/31/06
Project: Research project
HEREGULIN (GP30) EXPRESSION AND DRUG RESISTANCE
Lupu, R.
National Cancer Institute
6/1/95 → 1/31/98
Project: Research project
HEREGULIN (GP30) IN BREAST CANCER TUMOR PROGRESSION
Lupu, R.
National Institute of Diabetes and Digestive and Kidney Diseases
9/30/94 → 8/31/04
Project: Research project

8762 Citations
54 Scopus h-Index
106 Article
12 Review article
5 Letter
3 Comment/debate
More
- 2 Short survey

Fatty acid synthase confers tamoxifen resistance to er+/her2+ breast cancer
Menendez, J. A., Papadimitropoulou, A., Steen, T. V., Cuyàs, E., Oza-Gajera, B. P., Verdura, S., Espinoza, I., Vellon, L., Mehmi, I. & Lupu, R., Mar 1 2021, In: Cancers. 13, 5, p. 1-19 19 p., 1132.
Research output: Contribution to journal › Article › peer-review

Open Access
Fatty acid synthase is a key enabler for endocrine resistance in heregulin-overexpressing luminal b-like breast cancer
Menendez, J. A., Mehmi, I., Papadimitropoulou, A., Steen, T. V., Cuyàs, E., Verdura, S., Espinoza, I., Vellon, L., Atlas, E. & Lupu, R., Oct 2 2020, In: International journal of molecular sciences. 21, 20, p. 1-14 14 p., 7661.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Heregulin drives endocrine resistance by altering il-8 expression in er-positive breast cancer
Papadimitropoulou, A., Vellon, L., Atlas, E., Steen, T. V., Cuyàs, E., Verdura, S., Espinoza, I., Menendez, J. A. & Lupu, R., Oct 2 2020, In: International journal of molecular sciences. 21, 20, p. 1-15 15 p., 7737.
Research output: Contribution to journal › Article › peer-review

Open Access
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer
Menendez, J. A., Peirce, S. K., Papadimitropoulou, A., Cuyàs, E., Steen, T. V., Verdura, S., Vellon, L., Chen, W. Y. & Lupu, R., Dec 31 2020, In: Aging. 12, 24, p. 24671-24692 22 p.
Research output: Contribution to journal › Article › peer-review
Tumor cell-intrinsic immunometabolism and precision nutrition in cancer immunotherapy
Cuyàs, E., Verdura, S., Martin-Castillo, B., Alarcón, T., Lupu, R., Bosch-Barrera, J. & Menendez, J. A., Jul 2020, In: Cancers. 12, 7, p. 1-27 27 p., 1757.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations